Wearables & Trackers

Why This Guide Matters

Baby monitors and infant wearables are one of the fastest-growing segments of nursery gear, with U.S. market revenue exceeding $1.5 billion annually. Parental anxiety drives demand, and manufacturers compete on sensor sophistication, app features, and reassurance-focused marketing. The result is a category where products look credible but vary enormously in what they actually measure -- and whether those measurements mean anything.

The central questions are not about features. They are about regulatory status, published accuracy, and behavioral effects. Does the sensor measure what it claims? Has that measurement been validated against a clinical reference standard? And when an alert fires at 2 a.m., what does the evidence say about how you will respond?

Three facts ground this guide. First, no device currently sold over the counter has been proven to prevent SIDS. Second, the FDA cleared its first OTC infant pulse oximeter -- the Owlet Dream Sock -- only in late 2023, years after ordering the company to stop selling its predecessor product. Third, documented cybersecurity incidents show baby monitors are actively targeted by bad actors. Understanding what a product actually is -- medically, legally, and technically -- is the prerequisite for using it wisely.

Product Category Breakdown

Nine distinct product types occupy this space. FDA regulatory status, sensor methodology, and cybersecurity footprint vary sharply across them. Understanding which category a product falls into is the first step in evaluating it.

1. 01 Wearable Pulse Oximetry -- FDA-Cleared

   Devices cleared by the FDA to measure heart rate and blood oxygen saturation (SpO2). The Owlet Dream Sock received De Novo clearance for OTC use in late 2023 (ages 1--18 months, 6--30 lbs). The Owlet BabySat received 510(k) clearance in June 2023 as a prescription-only device for clinical use. FDA clearance means accuracy was validated against clinical-grade pulse oximeters. These are the only consumer infant wearables with validated cardiorespiratory monitoring claims. Both are for monitoring only -- neither is cleared to prevent SIDS or as a substitute for clinical evaluation.

2. 02 Wearable Pulse Oximetry -- Wellness Class

   Numerous brands sell infant wearables that display heart rate and oxygen-level data but are not FDA-cleared. Manufacturers avoid clearance requirements by carefully limiting marketing language to general wellness claims -- "tracks sleep," "monitors movement" -- while displaying SpO2 or heart-rate numbers in the companion app. The underlying sensors may use similar hardware to cleared devices, but no accuracy validation against a clinical reference has been conducted or published. Parents interpreting these readings for health decisions are doing so without validated data.

3. 03 Clip-on and Sock Movement Monitors

   Devices such as Snuza Hero and Sense-U clip to a diaper or fit on a foot and primarily detect abdominal or body movement. Not cleared for oxygen measurement. Movement monitoring provides some utility as a motion alarm -- absence of movement for a threshold period triggers an alert. These devices do not measure cardiorespiratory function directly. The Snuza Hero MD holds European medical device certification but is not FDA-cleared in the United States.

4. 04 Camera-Based Sleep Analytics

   Nanit and Miku use camera or radar technology to estimate breathing rate and sleep patterns without physical contact with the infant. Nanit Pro tracks breathing motion via video analysis. Miku uses ultrasonic radar. Neither product is FDA-cleared for breathing rate monitoring. Both rely heavily on cloud infrastructure -- video streams and analytics are processed and stored remotely. This creates a high cybersecurity footprint: persistent cloud access, third-party data processing, and camera streams that can be targeted if account credentials are compromised.

5. 05 Under-Mattress Sensor Pads

   Devices like Angelcare and older Babysense models place a sensor pad beneath the mattress to detect movement vibration. Not FDA-cleared. Older Angelcare products were subject to CPSC recalls related to cord strangulation hazards; current versions are redesigned. Sensor sensitivity is affected by mattress thickness and material, and sensor drift over time is a known limitation. Motion-based alerts require careful threshold calibration to minimize false alarms without missing real events.

6. 06 Smart Pajamas and Sensor-Embedded Clothing

   Mimo, Nanit Breathing Band, and similar products integrate sensor electronics into garment fabric. Sensor accuracy degrades with wash cycles and wear. Electrode or sensor contact depends on garment fit -- a poor fit in a growing infant produces unreliable readings. Comfort and thermal regulation during wear should be monitored; sensor patches and rigid housings can create pressure points. OEKO-TEX or GOTS certification for the fabric component is a useful quality signal for the material itself, separate from sensor performance.

7. 07 Wearable and Connected Thermometers

   Continuous-wear fever monitoring patches (TempTraq, Fever Smart) and connected spot-check thermometers provide temperature tracking with app logging. Some continuous thermometer patches have received FDA 510(k) clearance for fever monitoring as Class II medical devices. This is a more clinically defensible category than cardiorespiratory monitoring -- continuous fever tracking has clear value in febrile illness management. Adhesive patches can cause skin irritation with extended wear; daily skin checks are recommended.

8. 08 GPS Trackers and Child Locators

   Purpose-built cellular GPS trackers (AngelSense, Jiobit/LG) update location continuously over 4G LTE networks and are designed for children who need active monitoring. Bluetooth crowd-sourced trackers (AirTags, Tile) depend on nearby devices in the network to relay location -- in low-density environments, location data can be 30 minutes to several hours stale. AirTags are not suitable as primary child safety trackers for this reason. COPPA compliance is critical: GPS trackers marketing for use with children that collect location data must comply with federal requirements and ideally carry a recognized Safe Harbor seal.

9. 09 Kids' Smartwatches

   4G LTE watches for older children (Xplora, TickTalk, Gabb Watch) offer GPS tracking, calling, and limited messaging. Best-in-class products are whitelist-only -- only parent-approved contacts can communicate -- and carry COPPA Safe Harbor certification. Devices without a camera reduce privacy risk. The January 2025 COPPA Rule update expanded covered data to include inferred behavioral data and biometric data, raising the compliance bar for smartwatch manufacturers. A product that lacks a COPPA Safe Harbor seal should be evaluated carefully against the updated rule before purchase.

Categories at a Glance

FDA Medical Device vs. Wellness Device

The distinction between an FDA-cleared medical device and a wellness-class consumer product is the most important concept for evaluating infant monitors. These two categories can be physically identical -- the same sensor hardware, the same app, sold in similar packaging -- but they represent fundamentally different regulatory pathways and carry fundamentally different accuracy guarantees.

The Medical Device Definition

Under Section 201(h) of the Federal Food, Drug, and Cosmetic Act, a medical device is any instrument, apparatus, or contrivance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. Any infant monitor claiming to detect dangerous oxygen levels, prevent SIDS, or diagnose abnormal heart rhythms falls within this definition and requires FDA clearance before marketing.

Three clearance pathways are relevant for infant monitor manufacturers:

• 510(k) Clearance: Demonstrates substantial equivalence to a legally marketed predicate device. Most Class II (moderate-risk) medical devices use this pathway. FDA reviews evidence that the new device is as safe and effective as the predicate.
• De Novo Classification: For novel, low-to-moderate-risk devices with no predicate. The manufacturer proposes a new device type and risk-based regulatory controls. FDA grants or denies classification. Owlet Dream Sock obtained De Novo clearance, establishing OTC infant wearable pulse oximetry as a new device type.
• Premarket Approval (PMA): Required for high-risk Class III devices. Requires clinical trial data demonstrating safety and effectiveness. Rarely used for consumer-facing infant monitors.

The Owlet Timeline

Owlet is the most instructive case study in this regulatory landscape:

• 2016: FDA raises concerns about Owlet's marketing claims for the Smart Sock, noting that claims about monitoring heart rate and oxygen levels in infants constitute medical device claims requiring clearance.
• October 1, 2021: FDA issues a formal Warning Letter to Owlet, finding the Smart Sock to be an unauthorized medical device. Owlet is required to cease distribution.
• June 20, 2023: Owlet BabySat receives 510(k) clearance (K221910) as a prescription-only device intended for use under medical supervision.
• Late 2023: Owlet Dream Sock receives De Novo clearance for OTC use, ages 1--18 months, weighing 6--30 lbs. This is the first FDA-cleared OTC infant wearable pulse oximeter.

The arc from warning letter to OTC clearance illustrates how long proper regulatory validation takes. Products that skipped this process -- including Owlet's own non-cleared versions during those years -- were selling devices with unvalidated accuracy claims.

The Wellness Device Escape Hatch

FDA's 2016 General Wellness Policy states the agency will exercise enforcement discretion for low-risk devices making general wellness claims -- claims related to maintaining or encouraging a general state of health. A company can sell an infant monitor with SpO2 and heart rate displays without FDA clearance if it carefully avoids language connecting those readings to disease diagnosis, prevention, or treatment.

In practice, this creates a gray zone. A product can display a heart rate number and an oxygen percentage in an app, include a configurable alarm when values fall outside a range, and still be classified as a wellness device -- provided the marketing materials say "tracks your baby's wellness" rather than "detects dangerous oxygen drops." Parents interpreting the same readings for health decisions receive none of the accuracy guarantees required of cleared devices.

AAP Position and Clinical Evidence

The American Academy of Pediatrics (AAP) 2022 Safe Sleep Guidelines explicitly state that home cardiorespiratory monitors are not recommended to reduce the risk of SIDS or other sleep-related infant deaths in healthy infants. This position is grounded in the absence of any randomized controlled trial showing that consumer monitoring reduces SIDS incidence, combined with documented harms from false alarms and behavioral changes in monitored households.

The CHIME Study (JAMA, 2001)

The Collaborative Home Infant Monitoring Evaluation (CHIME) study enrolled 1,079 infants across five clinical sites, including healthy term infants, preterm infants, and infants with prior apparent life-threatening events (ALTEs). All participants were monitored with cardiorespiratory monitors; outcome data were compared across groups and against historical SIDS rates.

The study found no difference in SIDS rate between monitored infants and historical unmonitored cohorts. Most monitor alarms corresponded to events that resolved spontaneously without intervention. The CHIME study remains the primary evidence base for the AAP's position against routine home monitoring for SIDS prevention.

Bonafide et al. 2018 (JAMA)

This prospective accuracy study examined consumer infant wearables in a clinical setting. Researchers enrolled 30 hospitalized infants aged 0--6 months experiencing clinically confirmed hypoxemic events (SpO2 below 80% for at least 10 seconds) or bradycardic events. The Owlet Smart Sock 2 and Baby Vida were tested simultaneously alongside clinical-grade monitoring (DOI: 10.1001/jama.2018.9018).

• Owlet Smart Sock 2: 88.8% sensitivity for hypoxemia detection, with 26 false alarms during the monitoring period.
• Baby Vida: 0% sensitivity for hypoxemia. The device failed to detect any of the clinically confirmed events in the study cohort.

Neither product tested in this study is currently available in the same form -- both have been updated or replaced. The findings cannot be applied directly to current products. However, the study established a methodological benchmark and demonstrated that consumer devices vary enormously in detection capability. It also highlighted that 88.8% sensitivity -- the better-performing result -- means roughly one in nine genuine hypoxemic events goes undetected.

False Alarms and Alert Fatigue

False alarms are not harmless. Research on clinical alarm fatigue -- extensively studied in hospital ICU settings -- documents a consistent behavioral pattern: repeated alarms that turn out to be non-actionable lead caregivers to respond more slowly, or not at all, to subsequent alerts. Consumer wearables with high false-alarm rates create the same dynamic in home settings, potentially desensitizing caregivers to alerts over time. The Bonafide study recorded 26 false alarms across 30 infants with the better-performing device in the study.

False Reassurance

The inverse failure -- a sensor that generates no alert during a genuine physiological event -- is the more dangerous failure mode. A caregiver who trusts their monitor may respond more slowly, apply less vigilance to safe sleep practices, or interpret the absence of alerts as evidence that their infant is fine. The AAP's position is that no consumer wearable should substitute for the evidence-based safe sleep environment that does have demonstrated protective effect.

Risk Catalog

Risks in this category divide into three types: measurement risks (the device misinforms), physical safety risks (the device itself causes harm), and behavioral risks (device use changes caregiver behavior in harmful ways). All three are documented.

1. 01 Inaccurate Readings

   Pulse oximeter accuracy is affected by motion artifact, low perfusion states, skin pigmentation (melanin absorbs near-infrared light used by the sensor), probe positioning and pressure, and sensor degradation over time. The FDA requires cleared devices to validate accuracy across skin tones and motion conditions. Wellness-class devices provide no such validation. A reading that looks plausible may be wrong. Clinical-grade pulse oximetry uses arterial blood gas co-oximetry as the reference standard; no consumer wearable provides this level of measurement.

2. 02 False Alarms and Alert Fatigue

   High false-alarm rates are documented in clinical testing of consumer infant wearables. The Bonafide 2018 JAMA study recorded 26 false alarms with the Owlet Smart Sock 2 across 30 infants during the study period. Repeated non-actionable alerts produce behavioral habituation -- caregivers begin to discount, delay, or silence alerts. Alert fatigue is well-characterized in hospital monitoring literature and transfers directly to home settings. A monitor with a high false-alarm rate can create desensitization to alerts over time regardless of the device's detection sensitivity.

3. 03 False Reassurance from Silent Failure

   A device that fails to alert during a genuine physiological event -- either because sensor accuracy is low (Baby Vida: 0% sensitivity) or because the sensor was improperly positioned or displaced -- creates a false sense of safety. A caregiver who trusts the device may take longer to check their infant, apply less vigilance to safe sleep practices, or interpret the absence of alerts as confirmation that everything is fine. The AAP's position against using monitors to replace safe sleep practices reflects this specific concern.

4. 04 Skin Irritation and Contact Reactions

   Continuous-wear sensors -- adhesive patches, wrist or ankle straps, foot socks worn for extended periods -- can cause localized skin reactions. Occlusion under adhesive material prevents normal skin thermoregulation and can cause maceration, pressure injury, or contact dermatitis. Rotate sensor placement daily, inspect skin at every removal, and follow manufacturer age and size guidelines carefully. Rigid sensor housings should not be placed directly over bony prominences. Sizing matters -- a device that fit correctly at birth will not fit correctly at three months.

5. 05 Battery Safety

   Lithium-ion batteries in wearable monitors carry thermal runaway risk if damaged, swollen, or improperly charged. Never charge devices inside or directly adjacent to the crib. Discard any device with a swollen or damaged battery immediately. Under Reese's Law (16 CFR Part 1263, effective September 21, 2024), devices containing button or coin cell batteries must meet compartment security requirements -- the battery door must require a tool to open. Confirm this before placing any button-battery device near an infant.

6. 06 Cord Strangulation

   Camera monitors mounted above or adjacent to the crib introduce power cords and mounting hardware into the sleep environment. Older Angelcare models were subject to CPSC recalls for cord strangulation fatalities. Current CPSC guidance and most manufacturer instructions require that cords be kept a minimum of 3 feet from the crib and secured against the wall. Camera angles that provide useful imagery often encourage placement within cord-reach range if mounting guidelines are not followed carefully. Verify the finished installation before first use and after any repositioning.

7. 07 Weighted Sleep Products

   Some wearable-adjacent products include weighted elements -- weighted swaddles, weighted sleep sacks, or blankets with weighted inserts -- marketed to reduce movement alerts or promote calmer sleep. The AAP explicitly recommends against all weighted swaddles, weighted blankets, and any sleep surface or garment add-on that adds weight to an infant's chest. The primary concern is positional asphyxia from weight restricting chest expansion, especially in younger infants with limited head-repositioning ability.

8. 08 Overheating

   Continuous-wear sensors can trap heat at the skin surface, particularly adhesive patches covering larger areas of body surface. Overheating is an independent risk factor associated with SIDS in the epidemiological literature. Monitor skin temperature and overall infant warmth during sensor use, especially in warmer environments. Follow manufacturer guidance on maximum continuous wear duration and remove the sensor if the underlying skin appears flushed or significantly warmer than surrounding tissue.

9. 09 Cybersecurity and Unauthorized Access

   Connected baby monitors are documented targets for unauthorized access -- remote viewing of video streams, audio intrusion, and in some cases manipulation of device features. Attack vectors include credential stuffing (attackers use email/password pairs leaked from unrelated breaches), default password exploitation, and unencrypted local network video streams. These incidents are not theoretical: documented cases include camera hijackings in Houston (December 2018), Seattle (November 2019), and Texas (2013) in which attackers spoke through monitors to families. The Privacy and Cybersecurity section covers specific defenses.

Risks at a Glance

Privacy and Cybersecurity

Baby monitors are among the most frequently documented targets in consumer IoT security research. Unlike most smart home devices, they operate continuously, are positioned in a private room, capture audio and video of sleeping infants and parents, and are often configured once and left running indefinitely. This profile makes them attractive targets and difficult for families to monitor for unauthorized access.

Documented Incidents

These are not hypothetical scenarios. Each of the following involved a real family and a commercially sold product:

• Texas, 2013 (Foscam camera): A hacker remotely accessed an IP camera in a toddler's room and spoke to the child through the monitor's speaker while the parents were present. This was among the first widely publicized baby monitor hacks and brought broad attention to default-password vulnerabilities in IP cameras.
• Houston, TX, December 2018 (Nest Cam): A hacker accessed a family's Nest Cam, made threatening statements, and played an emergency broadcast through the device. The access vector was credential stuffing -- the family had reused a password from another account that appeared in a prior data breach.
• Seattle, WA, November 2019 (Fredi / Taococo cameras): A hacker surveilled a Seattle family and spoke through their camera. Security researchers subsequently identified that the same vulnerability affected thousands of identical-hardware cameras sold under multiple brand names, many of which shipped with factory-default credentials and no firmware update mechanism.

Attack Mechanisms

Understanding how these attacks occur makes defenses concrete and actionable:

• Credential stuffing: Attackers obtain leaked username/password lists from prior data breaches -- widely available on dark-web marketplaces -- and test them systematically against device companion apps. If you reuse a password from a previously breached account, credential stuffing will very likely succeed.
• Default password exploitation: Many budget cameras ship with identical factory-default credentials (admin/admin, or the device serial number as the password). If the default password is never changed, anyone with knowledge of the default for that model has access.
• Unencrypted local streams: Some monitors broadcast video over the local network using HTTP rather than HTTPS with TLS encryption. Any device on the same Wi-Fi network can intercept the stream without authentication.
• Unauthenticated control channels: Rapid7 and other security researchers have published disclosures showing that some cameras allow pan/tilt commands or firmware updates without any authentication, accessible to anyone on the same local network.

COPPA and Child Data

The Children's Online Privacy Protection Act (COPPA) requires verifiable parental consent before collecting personal information from children under 13. The FTC's January 2025 COPPA Rule update expanded the definition of personal information to include biometric data, precise geolocation data, and inferred behavioral data derived from activity patterns. GPS trackers and smartwatches marketed for use with children that collect location or behavioral data are subject to these requirements.

Manufacturers can achieve Safe Harbor status through third-party programs: kidSAFE, ESRB Privacy Certified, iKeepSafe COPPA Safe Harbor, PRIVO, and TRUSTe Kids. A Safe Harbor seal indicates that an independent third party has reviewed the product's data practices against the COPPA rule. It is not a guarantee of perfect compliance, but it is meaningfully stronger than self-certification.

Data Collected by Connected Monitors

Understand what data leaves your home before purchasing. Connected baby monitors may collect and transmit:

• Continuous or on-demand video and audio streams from the nursery
• Physiological data: heart rate, SpO2, temperature, movement patterns
• Sleep analytics derived from video or sensor data
• Location data from GPS-enabled devices
• App account data: email address, device identifiers, IP address, usage logs
• Inferred behavioral data: sleep schedule patterns, developmental milestone tracking, app engagement history

Cybersecurity Filters to Apply

1. Enable 2FA immediately. Use an authenticator app rather than SMS where possible. Change any default password before placing the device in your home. Use a strong, unique password not reused from any other service or account.
2. Update firmware promptly. Security patches are frequently bundled with firmware updates. Enable automatic updates if the device offers them. Confirm the product still receives security updates before purchasing older or discontinued models.
3. Review the privacy policy before purchase. Key questions: who can access data beyond the primary account holder; how long is data retained; is video or physiological data sold or licensed to third parties; can you request deletion; and where are servers located?
4. Prefer local-only operation where available. Some cameras offer local storage (SD card) and local network streaming without cloud relay. This substantially reduces the cybersecurity footprint. If cloud features are not needed, disable them.
5. Isolate devices on a dedicated IoT network. Consumer routers increasingly support network segmentation. An isolated IoT network prevents a compromised camera from accessing other home devices such as computers, phones, or smart locks on the main network.
6. Be cautious with brands lacking U.S. or EU corporate presence. Manufacturers without a domestic legal entity are significantly harder to hold accountable in the event of a breach or when security vulnerabilities need to be disclosed and patched. Security researchers have repeatedly found these devices have the weakest security postures.
7. Disable remote access if you do not use it. Remote viewing over the internet requires the device to be accessible from outside your home network. Disabling this feature when not needed reduces the external attack surface substantially.
8. Note on AirTags as child trackers: Apple AirTags use the Find My Bluetooth crowd-sourced network. Location is updated only when an iPhone passes physically near the tag. In lower-density residential or outdoor environments, location data can be 30 minutes to several hours stale. AirTags are well-suited to tracking bags and luggage in high-traffic areas; they are not appropriate as primary real-time child safety trackers. Purpose-built cellular GPS devices (AngelSense, Jiobit) provide continuous location updates and are more appropriate for children requiring active monitoring.

Certifications Explained

Certifications in this category divide into mandatory regulatory requirements, meaningful voluntary validations, and unregulated marketing claims. Knowing which is which prevents you from being misled by impressive-sounding labels.

Certifications at a Glance

Safe Use Habits

These habits apply across monitor types. The first three are the highest impact -- all others are secondary but still important.

1. 01

   Treat the device as supplemental, not a substitute

   The evidence-based SIDS reduction strategy is the AAP Safe Sleep Environment: firm, flat, separate sleep surface; back-to-sleep positioning; room-sharing for at least the first 6 months; no soft objects, pillows, or loose bedding in the crib. No consumer monitor has been shown to reduce SIDS incidence. Use any device as a supplemental tool only. Decisions about your infant's wellbeing should always begin with direct assessment of the infant, not device readings.

2. 02

   Enable 2FA on the companion app immediately

   Two-factor authentication prevents credential stuffing -- the most common vector for unauthorized camera access. Use an authenticator app (Google Authenticator, Authy, or equivalent) rather than SMS-based 2FA where possible. Do this before placing the device in your home. A monitor with default credentials or a reused password is a security liability from the moment it is connected.

3. 03

   Use a strong, unique password

   Do not reuse a password from any other account or service. Use a password manager to generate and store a unique credential for the monitor app. Even if another account is breached in an unrelated incident, a unique password prevents that breach from compromising your baby monitor. This is the single highest-impact security action available to most users.

4. 04

   Install firmware updates promptly

   Security vulnerabilities in camera and device firmware are regularly discovered and patched. Enable automatic updates if supported. Check the manufacturer's support page before purchasing older models -- a device that no longer receives firmware updates is permanently vulnerable to any known exploit. Discontinued products from manufacturers who no longer provide security support should be retired, not repurposed.

5. 05

   Keep power cords 3+ feet from the crib

   Camera monitors require continuous power. CPSC guidance and manufacturer installation instructions specify that all cords must be routed and secured at least 3 feet from the crib perimeter. Use cable management to route cords along walls and away from the sleep area. Verify the installation before first use and after any repositioning. A camera angle that seems ideal may not be achievable within safe cord distance -- always choose safety over viewing angle.

6. 06

   Rotate sensor placement and inspect skin daily

   For continuous-wear sensors -- foot socks, ankle straps, adhesive patches -- inspect the underlying skin every time the device is removed. Look for redness, pressure marks, skin breakdown, or contact dermatitis. Rotate placement to different sites where possible. Confirm sizing as the infant grows; a sock or strap that fit correctly last month may no longer fit. Never place rigid sensor housings directly over bony prominences.

7. 07

   Handle batteries safely

   Charge rechargeable devices outside the crib -- never on or adjacent to the sleep surface. Discard any device with a swollen, leaking, or damaged battery immediately; do not attempt to discharge or repair it. Before placing any device with a button or coin cell battery near an infant, verify that the battery compartment is secured with a screw or tool-required fastener as required by Reese's Law (16 CFR Part 1263). A compartment secured only by friction or a snap does not comply.

8. 08

   Assess your infant directly before acting on any alert

   When a monitor alerts, your first action is direct visual and physical assessment of your infant -- not reading the app or waiting for it to update. False alarms are documented even in FDA-cleared devices. Conversely, a silent monitor is not proof that your infant is fine. Establish a household protocol: any significant alert triggers direct infant assessment before any other response. This habit prevents both the false-reassurance trap (trusting a silent device) and the alert-fatigue trap (dismissing alarms without checking).

Shopping Framework

Not every family needs a wearable monitor. Start with the purpose question: are you seeking cardiorespiratory monitoring for a specific clinical reason, or general peace of mind? The answer determines which tier is appropriate. Discuss any cardiorespiratory monitoring intention with your pediatrician before purchasing -- especially if motivated by a prior ALTE, prematurity, or family history.

Bottom Line

Sources